Salomon Manier, MD, PhD, Lille University, Lille, France, discusses the role of triplet combinations in the treatment of transplant-ineligible, frail myeloma patients, and further highlights the importance of continuing to improve treatment strategies for these patients. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.